CA1084300A - Instrument for determining the contents of metabolic products in the blood - Google Patents
Instrument for determining the contents of metabolic products in the bloodInfo
- Publication number
- CA1084300A CA1084300A CA272,129A CA272129A CA1084300A CA 1084300 A CA1084300 A CA 1084300A CA 272129 A CA272129 A CA 272129A CA 1084300 A CA1084300 A CA 1084300A
- Authority
- CA
- Canada
- Prior art keywords
- blood
- instrument
- laser
- metabolic products
- atr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/55—Specular reflectivity
- G01N21/552—Attenuated total reflection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/203332—Hydroxyl containing
- Y10T436/204165—Ethanol
Abstract
Abstract of the Disclosure A method and instrument for determining the amounts of metabolic products in blood using a laser beam guided through an ATR plate placed against a blood supplied biological tissue.
The intensity of the beam is then detected after being affected by the blood containing the metabolic elements and is used to determine the amounts of metabolic products in the blood.
The intensity of the beam is then detected after being affected by the blood containing the metabolic elements and is used to determine the amounts of metabolic products in the blood.
Description
~ 4~
¦ B~CI,G~)U~ Ol. TIIE INVl~NT:~ON
l'he inventior, ~elates to an instrument ~or deter~nining ?
th~3 amount~; o:E metabolic pro~ucts in the blood by means o:E a radi.ation source and a radiati.on detection system deliverin~J an output signal clepenclillg on the intensity o~ radia~ion o-~ th~
aforesaid source after it has be~n af~ected by the bl~od I
containing the metabolic products~ .
GeneralIyl the determination o~ amounts of metabo:L:I.c p.roducts such as polypeptides, urea, cholesterol, g~cose, CO2 or ethyl alcohol in the blood is carried out by with~rawiny blood from the body and examining it chemically. ~Iowever, the `;
time required for ascertaining the particular amounts is relatively long and ranges from a few minutes to an hour. - ¦
O~ the one hand, there is danger in such ~x~ende~
periods of time that the blood may alter resulti.ng in spuri.ous ¦
results. On the other hand, a continuous testing of the me~a~olic~
I products, as is desirable for ins~ance when examining the glucose content w~en suspecting diabetes, or when det~rminlng 1~ 1 the:C02 content during artificial respiration in the course ~
an operation, is impossible. ~gain, it is .impossible, in- current te~hniques, to ~scertain transiently occurrin~, unl~TIown . 1 - -me~a~o1~c products. I ~
:~ : It~is fur.thermore known that the metabolic pro~ucts in ; .
I the blood absorb infrared (IR) xadiation, so that -they may be ~;
ascertained by means of absorption measurements. How~iver, such infrared absorption tests suffer from the difficulty that th~. :
blood acting as a solvent for the metabolic products in itself i. represents an aqueous solution which is strongly absorbing i~
the in~rarecl spectrum, as is well known~ Therefore, ~hen per .
forming measuxemenks by means of px~viously known ~R spect ~ ~ ¦
30 - I meters on the basis of trans~i.ssion, very minute ~llm :: -. :. : . : ., -.. . ...... . . . .
,~:: : . - . . . - - : .
~ 3 j~ thickllessc~ ar~ r~luired ~o obcain m~asurem~n~ ~ic3nals th~t ax~
1, useful ~t all. Irh; c~ ~clqu.ir~s in turn that the dissolved s~tbsta~ces to be test~d mus t be pres~nt a t very high ~ concentrations so tha-t a relatlve change in absorption can be 1 5 detected at all. Therefore only concentrations exceeding 1.
J percent can be ascertained in fact wheIl usin~ ~}~f prev.iously .
~ known IR sp~ctrometers.
i As shown by the article "Inrared Absorptlon .
~ Spectroscopy ofAqueous Solutions with a C02 Laser", Applied ! lo Physics, Magazine 7, pp. 287-293 (197S), the measurement i ¦ sensitivi.ty in infrared absorption tests using the transmission mode has been significantly improved by employing lasers with an essentially higher intensity than the previously known light sources. When lasers are used, however, there frequently occurs ¦ .
15 . the undesired side effect of appreciable heating of the substance :
. . to be examined due to the strong absorption properties of ~:
. aqueous solutions. This problem is rather easily met when i . testing aqueous solutions in inorganic materials availab1e in :
. ample amounts of solution. However, the tests are.significantly 1 20 more difficult if the same transmission measurements must ~e .
¦ : ~ carried out for blood, which is available only in lesser amounts :and which furthermore already denatures when heated to 45Co ~`
As was shown by applicant in an article in th~ book ~:.
Modern Technic~ues in Physiological Sciences, Academic Press, ~: ' ~ 25 London and New York, 1973, blood tests may also be carried out ¦ I in vivo by means of laser beams. In that experiment, venous I ¦ blood was passed in an extracorporeal shlmt through a cuve~.te ::! at a film ~llickness of 0.1 mm and at a flow rate o~ 30 cc per :
ii minute, and exsmined by means of a CO2 laser beam of 2 watts. . ~
¦1 It was found that the temperature of the blood bein~ tested .
, , , .
343~
j 1 could be k~:!p~ belo~ the ~ ical t~rnp~ra~u~ limi~ because of ¦l its high ~lol~ r~te, a~d -thc~-t -t/-0.5% change~s in con~entrati.~ns i ¦l ethanol Ol- ~lucose could readi:Ly be shown. However, this method l ¦ suffers from the dra~7back thal: the examination is exceedingly i 5 ¦ costly and practic~lly is 5Ui led only for large vperation.
I ¦ This method furthermore sufEers significantly from the problerQs ~ ¦ of achieving even flow through very thin cuvettes and then i I cleansing of same~
~ Again the ATR (Attenuated Total Reflectance) method ¦ 10 described by J. Fahrenfort in Molecular Spectroscopy, Proceedings~
of a Con~erence ai Brighton,_1968, Elsevier Publishing Company, Amsterdam, pp. 111-130, has already been used. In this method, . the radiation with which to examine a sample is so beamed into a suitable plate as to be totally reflected several times at oppositely located surfaces of this plate before being made to pass out of it and examined for changes in intensity. The salnple to be tested touches one or both sides of the plate totally reflecting the bea~.
- SUMMARY OF TNE INVENT'ION
The present invention now addresses the ta~ of providing an instrument allowing rapid, simple and accurat ~ - indication of the amounts of metabolic produots in the blood~
¦~- Starting with an instrument of the type initially ~
mentioned, this problem is solved by the invention in that the -~;
radiation source is an i~frared laser, and in that the laser radiation may be guided through an ATR plate into the boundaxy~
surface region of which may be brought the biood containing the ¦ metabo~ic products.
Surprisingly it was found that such an arrangement ~or the first time permits an extremely sharp separation of the individual metabolic products whioh is the basia requiremen~ for ,, .. . . .. , . ; . .. ... ,. ... . . . ... . . . . . , ... ~ . , . . . - . . .
43~0 ~ he ~ n~ tlt:ive cL(~term;ll;ltion of t:~lese inclividual producis.
¦l Yor :ill':t,~lllCe, as cliscuss~d in c~rea~er detall furth~r helow, the presellce oE cor~-tents in ethanol besides glucose c~n be ¦ unqu~stio~abIy .shown, ~hich was impossible with spec-trometers known previously.
Furtherlnore, this fact: must he considered wholly surprising and revolutionary, nclmely that the ins-trument of the invention for the first time allows also determining the contents of metabolic products ln the blood without ak all removing this blood Erom the body. This may be achieved by placing the ATR plate directly against the skin and especially against the tongue. It was wholly surpxising therefore that no difficulties due to tissue cell structure or overheating when ' ¦
locally applying laser beams were enc,ountered in the quantitatlve measurements, It was found that the power of the lasex used is only limited by the degree of absorption of the AT~ plate usedO ~
The invention opens up wholly new feasibilities of -examination and simplifies those already known. For instance, reliable serial tests for the early detection of' diabetes can now be carried out for the first time~ When testing for~glucose~ ~"
under stress, the essential advantage is obtained that no blood need be taken at regular intervals from the patient. ,, Lasers that my be adjusted with respect to wavelength were found to be especially suitable. Semiconductor-diode , ' lasers, parametric lasers and also gas lasers may be used.
¦¦ Parametric oscillators pumped by means of pulsed,neodym.ium and , tunable depending on the crystals from 1.4 to 4 microns (LiNbO3) ~¦ and from 1.22 -to 8.5 microns (prousti~e) are particularly ~' l¦ sultable.
Furthermore, both pulsed and continuous wave lasers 4~
1 may be u~;.?d. P~ll.se-lasers oller the s~ecial advantage of intro~ ci.ng onl~ millor stresses in th~ form oE heating the b:Loo~
being te~ted despite the high intensity available fox such tests. I
The angle of incidence of the laser beam with respect to the reflecting sur:eaces of the ATR plate are appropria~ely select.ed as the function of the AT~ matexial. PreEer~bl.y, howeverl,~
they fall within the range o~ 45-60.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention is explained below in greater detail, ¦
xefexring to the drawings, wherein:
. FIGURE 1 is a diagxammatic representation of a total reflection process; - ~:
FIGURE 2 is a diagram of an ATR plate; ;~
FIGURE 3 is a diagrammatic illustration of an instrument constructed according to the invent.ion; ~ 1 FIGURE 4 shows the relative transmission as~a func-tionj ~ ~ -of the wavenumber for two di~erent aqueous solutions r one containing l0~ by weight of g1ucose and the other 10% by volum~
of ethanol, measured with a conventional sp ctrometer and ~n ;
the same relative txansm1ssion scale; and FIGURE S shows the xelative txansmission as a function¦~
of wavenumber for two aqueous solutions, one with 0.45% by volume of ethanol and the other with 0.5% by weight of glucose,~
the measurements having been performed with an instrument o the Lnvention DETAILED DESCRIPTION OF THE INVENTION
Figure l merely shc~ws diagrammatically the principle of total re~lection, which occurs when the incident~light from ! an optically denser material of index o~ refraction nl is . . ~ ............................. ~ 6 ~
.. : :
, ,: .. , ; . , ::: , , : ' ~. - ; ~ ;
,. . , , :, ~ . ~ ; , . .
1~8~3~
incident on an optically less dense material o~ index of refraction n2 at an angle ~ exceeding the boundary total reflection angle obtained from the known laws of physical refraction. Essentially the total reflection phenomenon is characterized by no enersy transfer taking place rom the optically denser medium nl to the less denser optical medium n2 (n1 > n2) on the average. The electromagnetic field, however, does spread in a narxow boundary layer in the less dense optical medium. If the less dense optical medium is not transparent, the equilibrium between the incident and reflected ;
light energies ls disturbed by radiation absorption in the boundary layer. This process is termed the so-called attenuated total reflection, or ATR. This damped total reflection is used for spectroscopic purposes with the ATR plate generally denoted by 2 and shown in Figure 2.
This ATR plate 2 is shown in Figure 2 is of essentially trapezoidal cross-section and has two opposite surfaces 6 and 7 which are essntially parallel to each other. Beam 3 used for testing is coupled into the plate by means of one of the trape-.~. .
zoidal end faces. The beam then is totally reflected several `
times at surfaces 6 and 7 before exiting at the opposite trapezoidal end face in the form of beam 4. The intensity of beam 4 exiting from plate 2 now ma~ be affec~ed by depositing the substance to be tested, which in this instance is schematically shown as 5, on one or both boundary surfaces 6 and 7, or by bringing it into contact with either or both.
- The essential advantage in affecting beam 3 b~ the substance to be tested consists in the latitude of arbitrarily selecting the layer thickness for all practical purposes without ~30 thereby influencing the result obtained, obeying merely the ~ .. .
~r : ":
- 7 - ~
' . ; ' , ~ ' , . ` . . , ~ . ~
~V~3~3~)0 relation d >3 ~, where d is the layer thicknesc and ~ th~3 Il wavelen~h of the test beam.
¦ Se~reral ~TR plates for infrared spectroscopy already are kno~n. Plates macle from Germanium, Irtan 2, Irtan 6 ~r KRS 5 are preferred. rrhe only essential feature for this procedure is that the particular ATR plate absorb as ]ittle as possible of the beam ~eing used.
The information in beam 4 leaving the ATR plate .is the higher, obviously, the larger the number of reflections taking place at the boundary layer ~ouching the tested substancei On the other hand, the number of reflections clearly must be soj chosen so that the signal obtained from beam 4 can be unambiguously measured and processed. ATR plates with dimensions 15 mm by ~0-50 mm, and 1-2 mm thick, are used. The number of total reflections at the boundary layer with the ; ~-~
tested substance was ~rom 3 to 14. Good resul-ts are obtained when there were S total reflections at the boundary layer ~ ~:~
touching the tested substance. ~ ~;;
Figure 3 shows a diagrammatic embodiment o~ an ~-~20 ~ instrument of the invention. In this instrument, asln ~o-nventiona spectroscopy when measuring absorption, the method uses a reference beam. The radiation source is generally denoted by~
9 in Figure 3. This source consists of a laser 10, a tuning system 11 for the wavelength, an electronic Q-switch 12, and an 25 - output stabilizer 1:3. ~ ~ i A beam 18 generated by laser 10 is split by a semi-transmittlng~mirror into two half-~eams 16~and 17 wh1ch are made ;
to pass through the measurement cell 27, the latter containing 1 -- i! an ATR measurement plate 14 and an A~R refer~nce plate 15, both j~
30~ n the shape of prisms. The two hal-beams 16 and 17 after ~,,, .. , .
:
.
~ - 8 43()~
e~i-ting fr~m l-he measu~e~nerll: c~ll are combined by means o~
¦ rnirrors 22 ~rl~l 24 into a col~on beam l~ which then passe.s I throucJh a lens 26 and is incident on detector as of a s.i~nal ¦ processlns system generally desi~nated by 8.
¦ In order -to ob-tain higher.sensitivity, the two half-beams 16 and 17 are chopped in a know~ manner by means of a chopper 28 compr.ising a chopper wh~el 29. Chopper wheel 29 is provided ~ith a varying sequence of apertures and ~tops on two ~
different concentric circles so that the two half-beams 16 and :
17 are converted into alternating light of relatively diEferent frequencies. The frequency of rotation of a chopper motor can be varied in order to select the most favorable fre~uency range for the further processing of the signals obtained at detector 25.
lS Three types of detectors may be used in the spectral ¦~
range of lO m.icrons: the photo-conductive Germanium semi~
conductor detectors Ge:CU, Ge:Hg or Ge:Zn; the thermistors or pyroelectric trlglycine-sulfate (TGS); or BaSr-Tio4 based ~ :
detectors. The processing of the signals obtained from detector~ :
25 may be carried out in a known manner so that the potenkial ~ ;;
Ua(t) obtained at the output of the detector is split by two selectlve amplifiers in synchronism with ~he pertinent choppsr frequencies fm and fr into the respective proportional potentlals Um and Ur corre`sponding to the light outputs Pm f ¦ the reference beam and Pr of the measuring beam. ~
. I A differential amplifier then formsl\U = Ur ~ Um ~ I
, i . , . , ~
~ ¦ If the conditions in the reference and measuring chan~els are -I , the same, ~ U must be zero. Prior to each measurement, the , I . . , . , - .
control unit sets the null point by automatically balancing the 0 ¦,, differential amplifier. The difference in potentialf~U occuring during the measurement procedure is proportional to the I diEer~nce ln ]iyllt po~ter cau~.ed by the absorption of th~
,¦ measured me(~:ium~
~ P Pr m Following the normalization ¦ .
~ ~ U/UrC~ P/P ' a si~nal wiLl be available which is proportional to -the absorption constant X of the mea~ured medium and hence to its concentration in the solution, for instance blood. ¦~
In principle, any infrarecl laser may be used, but frequency-~unable lasers are particularly advan~ageous. For the I
embodiment shown in Figure 3~ tests were carried out. in particular with a 2 watt C0z laser and with a 5 watt model XB-5 by Apollo-Lasers, Inc. (USA). It was found in the course ;
o~ the measurements that measurement accuracy is hiyhly a~fected by the laser. In order to obtain high measurement a~curacy, care must be paid to using a laser of high stability regarding frequency, mode and power. The aoresaid Apollo laser essentlall meets these requirements.
The measurements carried out by means o the instrument ;~
described ln Flgure 3 in principle involves depositlon of~the~
solution to be rested on one surace o~ the ATR measuriny prlsm, ;
whlle a control solution lacking the materials being tested -~ ;
or in the case of blood, distilled water -- was deposited on ~ the corresponding surface of the ATR reference prism. ~
` ~ The comparison between Fiyures 4 and 5 is merely -ntended to provide an example of the wholly unexpected ` capabilities o~ the instrument of the invention. The curves of Figures 4 and 5 are plotted on the same abscissa scale, the !;
~, abscissa heing in wavenumbers. Figure 4 shows two di~ferent 3~ ¦¦ absorption curves, 30 and 31, recorded hy means o~ one o~ the !
best previously con~entional inErared spectrometers. The first - ., ,.: . ~ ........ . . ,, , . , . ` . .
l O ~ f ~ 3 curv~, 30, sho~s the reL~t.ive 7~ran~mis~:ion of an a~ueou~
so]a~t.l.on contain.in~ lOQi by vol~e of ~thanol as a Eunction oE
¦ a wavenuIlll7~r. The second curve, 31, shows the relative I transmis.sion of an aqueous solution containiny lO~ by ~Jeiyht of ~:
glucose. Both curves evidence a marked peak o absorption hetween, the wavenumbers lO00 and 1050. The expert immediately see~ that when measuring an aqueous solution simultaneously containing 10% by volume of ethanol and 106 by weight of glucose, the two .
absorption peaks can no longer be unambiguously distinguished, so that neither clear cut qualitative nor flawless quantitative :
conclusions would be possible from a corresponding absorption . .-mea.surement. .
Fi~ure 5 also shows two absorption.curves, 40 and 41, .
in the same representation. Cur~e 40 shows the absorption curve of an aqueous solution containing 0.45~ by volume o~ ethanol. .
I Curve 41 shows an aqueous solution containing 0.5% by weigh~-of glucose. The measurement of.the glucose absorption curve ~
unfortunately had to be terminated at a wavenumber slightly : :
. over lO00 hecause of being carried out with a CO2 laser. However, -the two curves clearly show that even in the presence of ~: ~ ~
. ....... . superposition of the curves, clearly separate evidence bo~h o ~ ~ ;
.... ethanol and of glucose is possible.
: When measuring metabolio products in the blood, tests were:performed in which the blood removed rom the body was .
I allowed to run over the measurement surface of ATR prism l~ or 1:
~ - . 1 be let to dry, and also in which the ATR measurement prism 14 I I was made ~o lie with its boundary sur~ace against the patient's I.I !' tongue. In every case quantitative measurements of an accuracy I;
~ I. of 5 mg% or 50 ppm. was obtained for metabolic products such l ::
:~ 30 '7l as glucose, cholesterol and uric acid. These values were I..
--, .
11 - .
:~l5 43~
veri~ied by corresponding measurements of conventional type.
When using the aforesaid Apollo laser of espaciall~ stable characteristics, a further very significant increase in sensitivity was obtained, by means of which concentrations of 1 mg% o~ lOppm could be ascertained.
The invention has been described in respect to measuring the amounts of metabolic products in the blood. It is apparent that the invention may also be used similarly to measure minute impurities in aqueous solutions. This can also be applied to monitoring and controlling ecological pollution, including industrial waste waters and for monitoring and controlling industrial processes in general.
The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiment is therefore to be considered in all repects-as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore inte~ded to be embraced therein.
-,, . ~
-12- ~
, . - - ~ ~ - - . , .
¦ B~CI,G~)U~ Ol. TIIE INVl~NT:~ON
l'he inventior, ~elates to an instrument ~or deter~nining ?
th~3 amount~; o:E metabolic pro~ucts in the blood by means o:E a radi.ation source and a radiati.on detection system deliverin~J an output signal clepenclillg on the intensity o~ radia~ion o-~ th~
aforesaid source after it has be~n af~ected by the bl~od I
containing the metabolic products~ .
GeneralIyl the determination o~ amounts of metabo:L:I.c p.roducts such as polypeptides, urea, cholesterol, g~cose, CO2 or ethyl alcohol in the blood is carried out by with~rawiny blood from the body and examining it chemically. ~Iowever, the `;
time required for ascertaining the particular amounts is relatively long and ranges from a few minutes to an hour. - ¦
O~ the one hand, there is danger in such ~x~ende~
periods of time that the blood may alter resulti.ng in spuri.ous ¦
results. On the other hand, a continuous testing of the me~a~olic~
I products, as is desirable for ins~ance when examining the glucose content w~en suspecting diabetes, or when det~rminlng 1~ 1 the:C02 content during artificial respiration in the course ~
an operation, is impossible. ~gain, it is .impossible, in- current te~hniques, to ~scertain transiently occurrin~, unl~TIown . 1 - -me~a~o1~c products. I ~
:~ : It~is fur.thermore known that the metabolic pro~ucts in ; .
I the blood absorb infrared (IR) xadiation, so that -they may be ~;
ascertained by means of absorption measurements. How~iver, such infrared absorption tests suffer from the difficulty that th~. :
blood acting as a solvent for the metabolic products in itself i. represents an aqueous solution which is strongly absorbing i~
the in~rarecl spectrum, as is well known~ Therefore, ~hen per .
forming measuxemenks by means of px~viously known ~R spect ~ ~ ¦
30 - I meters on the basis of trans~i.ssion, very minute ~llm :: -. :. : . : ., -.. . ...... . . . .
,~:: : . - . . . - - : .
~ 3 j~ thickllessc~ ar~ r~luired ~o obcain m~asurem~n~ ~ic3nals th~t ax~
1, useful ~t all. Irh; c~ ~clqu.ir~s in turn that the dissolved s~tbsta~ces to be test~d mus t be pres~nt a t very high ~ concentrations so tha-t a relatlve change in absorption can be 1 5 detected at all. Therefore only concentrations exceeding 1.
J percent can be ascertained in fact wheIl usin~ ~}~f prev.iously .
~ known IR sp~ctrometers.
i As shown by the article "Inrared Absorptlon .
~ Spectroscopy ofAqueous Solutions with a C02 Laser", Applied ! lo Physics, Magazine 7, pp. 287-293 (197S), the measurement i ¦ sensitivi.ty in infrared absorption tests using the transmission mode has been significantly improved by employing lasers with an essentially higher intensity than the previously known light sources. When lasers are used, however, there frequently occurs ¦ .
15 . the undesired side effect of appreciable heating of the substance :
. . to be examined due to the strong absorption properties of ~:
. aqueous solutions. This problem is rather easily met when i . testing aqueous solutions in inorganic materials availab1e in :
. ample amounts of solution. However, the tests are.significantly 1 20 more difficult if the same transmission measurements must ~e .
¦ : ~ carried out for blood, which is available only in lesser amounts :and which furthermore already denatures when heated to 45Co ~`
As was shown by applicant in an article in th~ book ~:.
Modern Technic~ues in Physiological Sciences, Academic Press, ~: ' ~ 25 London and New York, 1973, blood tests may also be carried out ¦ I in vivo by means of laser beams. In that experiment, venous I ¦ blood was passed in an extracorporeal shlmt through a cuve~.te ::! at a film ~llickness of 0.1 mm and at a flow rate o~ 30 cc per :
ii minute, and exsmined by means of a CO2 laser beam of 2 watts. . ~
¦1 It was found that the temperature of the blood bein~ tested .
, , , .
343~
j 1 could be k~:!p~ belo~ the ~ ical t~rnp~ra~u~ limi~ because of ¦l its high ~lol~ r~te, a~d -thc~-t -t/-0.5% change~s in con~entrati.~ns i ¦l ethanol Ol- ~lucose could readi:Ly be shown. However, this method l ¦ suffers from the dra~7back thal: the examination is exceedingly i 5 ¦ costly and practic~lly is 5Ui led only for large vperation.
I ¦ This method furthermore sufEers significantly from the problerQs ~ ¦ of achieving even flow through very thin cuvettes and then i I cleansing of same~
~ Again the ATR (Attenuated Total Reflectance) method ¦ 10 described by J. Fahrenfort in Molecular Spectroscopy, Proceedings~
of a Con~erence ai Brighton,_1968, Elsevier Publishing Company, Amsterdam, pp. 111-130, has already been used. In this method, . the radiation with which to examine a sample is so beamed into a suitable plate as to be totally reflected several times at oppositely located surfaces of this plate before being made to pass out of it and examined for changes in intensity. The salnple to be tested touches one or both sides of the plate totally reflecting the bea~.
- SUMMARY OF TNE INVENT'ION
The present invention now addresses the ta~ of providing an instrument allowing rapid, simple and accurat ~ - indication of the amounts of metabolic produots in the blood~
¦~- Starting with an instrument of the type initially ~
mentioned, this problem is solved by the invention in that the -~;
radiation source is an i~frared laser, and in that the laser radiation may be guided through an ATR plate into the boundaxy~
surface region of which may be brought the biood containing the ¦ metabo~ic products.
Surprisingly it was found that such an arrangement ~or the first time permits an extremely sharp separation of the individual metabolic products whioh is the basia requiremen~ for ,, .. . . .. , . ; . .. ... ,. ... . . . ... . . . . . , ... ~ . , . . . - . . .
43~0 ~ he ~ n~ tlt:ive cL(~term;ll;ltion of t:~lese inclividual producis.
¦l Yor :ill':t,~lllCe, as cliscuss~d in c~rea~er detall furth~r helow, the presellce oE cor~-tents in ethanol besides glucose c~n be ¦ unqu~stio~abIy .shown, ~hich was impossible with spec-trometers known previously.
Furtherlnore, this fact: must he considered wholly surprising and revolutionary, nclmely that the ins-trument of the invention for the first time allows also determining the contents of metabolic products ln the blood without ak all removing this blood Erom the body. This may be achieved by placing the ATR plate directly against the skin and especially against the tongue. It was wholly surpxising therefore that no difficulties due to tissue cell structure or overheating when ' ¦
locally applying laser beams were enc,ountered in the quantitatlve measurements, It was found that the power of the lasex used is only limited by the degree of absorption of the AT~ plate usedO ~
The invention opens up wholly new feasibilities of -examination and simplifies those already known. For instance, reliable serial tests for the early detection of' diabetes can now be carried out for the first time~ When testing for~glucose~ ~"
under stress, the essential advantage is obtained that no blood need be taken at regular intervals from the patient. ,, Lasers that my be adjusted with respect to wavelength were found to be especially suitable. Semiconductor-diode , ' lasers, parametric lasers and also gas lasers may be used.
¦¦ Parametric oscillators pumped by means of pulsed,neodym.ium and , tunable depending on the crystals from 1.4 to 4 microns (LiNbO3) ~¦ and from 1.22 -to 8.5 microns (prousti~e) are particularly ~' l¦ sultable.
Furthermore, both pulsed and continuous wave lasers 4~
1 may be u~;.?d. P~ll.se-lasers oller the s~ecial advantage of intro~ ci.ng onl~ millor stresses in th~ form oE heating the b:Loo~
being te~ted despite the high intensity available fox such tests. I
The angle of incidence of the laser beam with respect to the reflecting sur:eaces of the ATR plate are appropria~ely select.ed as the function of the AT~ matexial. PreEer~bl.y, howeverl,~
they fall within the range o~ 45-60.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention is explained below in greater detail, ¦
xefexring to the drawings, wherein:
. FIGURE 1 is a diagxammatic representation of a total reflection process; - ~:
FIGURE 2 is a diagram of an ATR plate; ;~
FIGURE 3 is a diagrammatic illustration of an instrument constructed according to the invent.ion; ~ 1 FIGURE 4 shows the relative transmission as~a func-tionj ~ ~ -of the wavenumber for two di~erent aqueous solutions r one containing l0~ by weight of g1ucose and the other 10% by volum~
of ethanol, measured with a conventional sp ctrometer and ~n ;
the same relative txansm1ssion scale; and FIGURE S shows the xelative txansmission as a function¦~
of wavenumber for two aqueous solutions, one with 0.45% by volume of ethanol and the other with 0.5% by weight of glucose,~
the measurements having been performed with an instrument o the Lnvention DETAILED DESCRIPTION OF THE INVENTION
Figure l merely shc~ws diagrammatically the principle of total re~lection, which occurs when the incident~light from ! an optically denser material of index o~ refraction nl is . . ~ ............................. ~ 6 ~
.. : :
, ,: .. , ; . , ::: , , : ' ~. - ; ~ ;
,. . , , :, ~ . ~ ; , . .
1~8~3~
incident on an optically less dense material o~ index of refraction n2 at an angle ~ exceeding the boundary total reflection angle obtained from the known laws of physical refraction. Essentially the total reflection phenomenon is characterized by no enersy transfer taking place rom the optically denser medium nl to the less denser optical medium n2 (n1 > n2) on the average. The electromagnetic field, however, does spread in a narxow boundary layer in the less dense optical medium. If the less dense optical medium is not transparent, the equilibrium between the incident and reflected ;
light energies ls disturbed by radiation absorption in the boundary layer. This process is termed the so-called attenuated total reflection, or ATR. This damped total reflection is used for spectroscopic purposes with the ATR plate generally denoted by 2 and shown in Figure 2.
This ATR plate 2 is shown in Figure 2 is of essentially trapezoidal cross-section and has two opposite surfaces 6 and 7 which are essntially parallel to each other. Beam 3 used for testing is coupled into the plate by means of one of the trape-.~. .
zoidal end faces. The beam then is totally reflected several `
times at surfaces 6 and 7 before exiting at the opposite trapezoidal end face in the form of beam 4. The intensity of beam 4 exiting from plate 2 now ma~ be affec~ed by depositing the substance to be tested, which in this instance is schematically shown as 5, on one or both boundary surfaces 6 and 7, or by bringing it into contact with either or both.
- The essential advantage in affecting beam 3 b~ the substance to be tested consists in the latitude of arbitrarily selecting the layer thickness for all practical purposes without ~30 thereby influencing the result obtained, obeying merely the ~ .. .
~r : ":
- 7 - ~
' . ; ' , ~ ' , . ` . . , ~ . ~
~V~3~3~)0 relation d >3 ~, where d is the layer thicknesc and ~ th~3 Il wavelen~h of the test beam.
¦ Se~reral ~TR plates for infrared spectroscopy already are kno~n. Plates macle from Germanium, Irtan 2, Irtan 6 ~r KRS 5 are preferred. rrhe only essential feature for this procedure is that the particular ATR plate absorb as ]ittle as possible of the beam ~eing used.
The information in beam 4 leaving the ATR plate .is the higher, obviously, the larger the number of reflections taking place at the boundary layer ~ouching the tested substancei On the other hand, the number of reflections clearly must be soj chosen so that the signal obtained from beam 4 can be unambiguously measured and processed. ATR plates with dimensions 15 mm by ~0-50 mm, and 1-2 mm thick, are used. The number of total reflections at the boundary layer with the ; ~-~
tested substance was ~rom 3 to 14. Good resul-ts are obtained when there were S total reflections at the boundary layer ~ ~:~
touching the tested substance. ~ ~;;
Figure 3 shows a diagrammatic embodiment o~ an ~-~20 ~ instrument of the invention. In this instrument, asln ~o-nventiona spectroscopy when measuring absorption, the method uses a reference beam. The radiation source is generally denoted by~
9 in Figure 3. This source consists of a laser 10, a tuning system 11 for the wavelength, an electronic Q-switch 12, and an 25 - output stabilizer 1:3. ~ ~ i A beam 18 generated by laser 10 is split by a semi-transmittlng~mirror into two half-~eams 16~and 17 wh1ch are made ;
to pass through the measurement cell 27, the latter containing 1 -- i! an ATR measurement plate 14 and an A~R refer~nce plate 15, both j~
30~ n the shape of prisms. The two hal-beams 16 and 17 after ~,,, .. , .
:
.
~ - 8 43()~
e~i-ting fr~m l-he measu~e~nerll: c~ll are combined by means o~
¦ rnirrors 22 ~rl~l 24 into a col~on beam l~ which then passe.s I throucJh a lens 26 and is incident on detector as of a s.i~nal ¦ processlns system generally desi~nated by 8.
¦ In order -to ob-tain higher.sensitivity, the two half-beams 16 and 17 are chopped in a know~ manner by means of a chopper 28 compr.ising a chopper wh~el 29. Chopper wheel 29 is provided ~ith a varying sequence of apertures and ~tops on two ~
different concentric circles so that the two half-beams 16 and :
17 are converted into alternating light of relatively diEferent frequencies. The frequency of rotation of a chopper motor can be varied in order to select the most favorable fre~uency range for the further processing of the signals obtained at detector 25.
lS Three types of detectors may be used in the spectral ¦~
range of lO m.icrons: the photo-conductive Germanium semi~
conductor detectors Ge:CU, Ge:Hg or Ge:Zn; the thermistors or pyroelectric trlglycine-sulfate (TGS); or BaSr-Tio4 based ~ :
detectors. The processing of the signals obtained from detector~ :
25 may be carried out in a known manner so that the potenkial ~ ;;
Ua(t) obtained at the output of the detector is split by two selectlve amplifiers in synchronism with ~he pertinent choppsr frequencies fm and fr into the respective proportional potentlals Um and Ur corre`sponding to the light outputs Pm f ¦ the reference beam and Pr of the measuring beam. ~
. I A differential amplifier then formsl\U = Ur ~ Um ~ I
, i . , . , ~
~ ¦ If the conditions in the reference and measuring chan~els are -I , the same, ~ U must be zero. Prior to each measurement, the , I . . , . , - .
control unit sets the null point by automatically balancing the 0 ¦,, differential amplifier. The difference in potentialf~U occuring during the measurement procedure is proportional to the I diEer~nce ln ]iyllt po~ter cau~.ed by the absorption of th~
,¦ measured me(~:ium~
~ P Pr m Following the normalization ¦ .
~ ~ U/UrC~ P/P ' a si~nal wiLl be available which is proportional to -the absorption constant X of the mea~ured medium and hence to its concentration in the solution, for instance blood. ¦~
In principle, any infrarecl laser may be used, but frequency-~unable lasers are particularly advan~ageous. For the I
embodiment shown in Figure 3~ tests were carried out. in particular with a 2 watt C0z laser and with a 5 watt model XB-5 by Apollo-Lasers, Inc. (USA). It was found in the course ;
o~ the measurements that measurement accuracy is hiyhly a~fected by the laser. In order to obtain high measurement a~curacy, care must be paid to using a laser of high stability regarding frequency, mode and power. The aoresaid Apollo laser essentlall meets these requirements.
The measurements carried out by means o the instrument ;~
described ln Flgure 3 in principle involves depositlon of~the~
solution to be rested on one surace o~ the ATR measuriny prlsm, ;
whlle a control solution lacking the materials being tested -~ ;
or in the case of blood, distilled water -- was deposited on ~ the corresponding surface of the ATR reference prism. ~
` ~ The comparison between Fiyures 4 and 5 is merely -ntended to provide an example of the wholly unexpected ` capabilities o~ the instrument of the invention. The curves of Figures 4 and 5 are plotted on the same abscissa scale, the !;
~, abscissa heing in wavenumbers. Figure 4 shows two di~ferent 3~ ¦¦ absorption curves, 30 and 31, recorded hy means o~ one o~ the !
best previously con~entional inErared spectrometers. The first - ., ,.: . ~ ........ . . ,, , . , . ` . .
l O ~ f ~ 3 curv~, 30, sho~s the reL~t.ive 7~ran~mis~:ion of an a~ueou~
so]a~t.l.on contain.in~ lOQi by vol~e of ~thanol as a Eunction oE
¦ a wavenuIlll7~r. The second curve, 31, shows the relative I transmis.sion of an aqueous solution containiny lO~ by ~Jeiyht of ~:
glucose. Both curves evidence a marked peak o absorption hetween, the wavenumbers lO00 and 1050. The expert immediately see~ that when measuring an aqueous solution simultaneously containing 10% by volume of ethanol and 106 by weight of glucose, the two .
absorption peaks can no longer be unambiguously distinguished, so that neither clear cut qualitative nor flawless quantitative :
conclusions would be possible from a corresponding absorption . .-mea.surement. .
Fi~ure 5 also shows two absorption.curves, 40 and 41, .
in the same representation. Cur~e 40 shows the absorption curve of an aqueous solution containing 0.45~ by volume o~ ethanol. .
I Curve 41 shows an aqueous solution containing 0.5% by weigh~-of glucose. The measurement of.the glucose absorption curve ~
unfortunately had to be terminated at a wavenumber slightly : :
. over lO00 hecause of being carried out with a CO2 laser. However, -the two curves clearly show that even in the presence of ~: ~ ~
. ....... . superposition of the curves, clearly separate evidence bo~h o ~ ~ ;
.... ethanol and of glucose is possible.
: When measuring metabolio products in the blood, tests were:performed in which the blood removed rom the body was .
I allowed to run over the measurement surface of ATR prism l~ or 1:
~ - . 1 be let to dry, and also in which the ATR measurement prism 14 I I was made ~o lie with its boundary sur~ace against the patient's I.I !' tongue. In every case quantitative measurements of an accuracy I;
~ I. of 5 mg% or 50 ppm. was obtained for metabolic products such l ::
:~ 30 '7l as glucose, cholesterol and uric acid. These values were I..
--, .
11 - .
:~l5 43~
veri~ied by corresponding measurements of conventional type.
When using the aforesaid Apollo laser of espaciall~ stable characteristics, a further very significant increase in sensitivity was obtained, by means of which concentrations of 1 mg% o~ lOppm could be ascertained.
The invention has been described in respect to measuring the amounts of metabolic products in the blood. It is apparent that the invention may also be used similarly to measure minute impurities in aqueous solutions. This can also be applied to monitoring and controlling ecological pollution, including industrial waste waters and for monitoring and controlling industrial processes in general.
The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiment is therefore to be considered in all repects-as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore inte~ded to be embraced therein.
-,, . ~
-12- ~
, . - - ~ ~ - - . , .
Claims (9)
1. An instrument for determining the contents of metabolic products in blood by means of a radiation source and a radiation detection system delivering an output signal depending on the intensity of the source's radiation after being affected by the blood containing the metabolic products, characterized in that the radiation source is an infrared laser, and in that the radiation generated by the laser is guided through an ATR plate to the boundary surface region of which the blood containing the metabolic products is brought.
2. An instrument as defined in claim 1, characterized in that the infrared laser is a continuous wave laser.
3. An instrument as defined in claim 2, characterized in that a laser with a power up to 4 watts and preferably from 0.5 to 2 watts is used.
4. An instrument as defined in claim 1, characterized in that a pulsed laser is used.
5. An instrument as defined by claim 1, characterized in that the laser beam is incident at an angle of incidence from 45° to 50°, preferably 50°, with respect to the surface of the ATR plate at the boundary surface region of which the blood is brought.
6. An instrument as defined by claim 5 characterized in that the ATR plate is of such dimensions and shape that the laser beam is subjected to reflections from 2 to 14 in number and preferably between 6 and 14 at the surface to the boundary region of which the blood is brought.
7. A method of determining the amounts of metabolic products in blood comprising the steps of placing an ATR
plate against a blood supplied biological tissue, guiding a laser beam through said ATR plate, and detecting the intensity of said beam after being affected by the blood-containing the metabolic elements.
plate against a blood supplied biological tissue, guiding a laser beam through said ATR plate, and detecting the intensity of said beam after being affected by the blood-containing the metabolic elements.
8. The method as defined in claim 7 which includes the step of reflecting said beam from 2 to 14 times, and preferably 6 to 14 times at the surface to the boundary region of which the blood is brought.
9. The method as defined in claim 7 wherein said laser beam has an angle of incidence from 45° to 60°, preferably 50°, with respect to the surface of the ATR plate at the boundary surface region of which the blood is brought.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762606991 DE2606991A1 (en) | 1976-02-20 | 1976-02-20 | DEVICE FOR DETERMINING THE CONTENT OF METABOLIC PRODUCTS IN THE BLOOD |
| DEP2606991.0 | 1976-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1084300A true CA1084300A (en) | 1980-08-26 |
Family
ID=5970482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA272,129A Expired CA1084300A (en) | 1976-02-20 | 1977-02-18 | Instrument for determining the contents of metabolic products in the blood |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4169676A (en) |
| JP (1) | JPS52102094A (en) |
| BE (1) | BE851606A (en) |
| CA (1) | CA1084300A (en) |
| CH (1) | CH612271A5 (en) |
| DE (1) | DE2606991A1 (en) |
| FR (1) | FR2341866A1 (en) |
| GB (1) | GB1531375A (en) |
| IT (1) | IT1071579B (en) |
| LU (1) | LU76810A1 (en) |
| NL (1) | NL7701778A (en) |
| SE (1) | SE7701901L (en) |
Families Citing this family (113)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS202434B1 (en) * | 1979-01-09 | 1981-01-30 | Ivan Dolejsi | Method of detec ing the malign ulcers from the the urine samples |
| DE2934190A1 (en) * | 1979-08-23 | 1981-03-19 | Müller, Gerhard, Prof. Dr.-Ing., 7080 Aalen | METHOD AND DEVICE FOR MOLECULAR SPECTROSCOPY, ESPECIALLY FOR DETERMINING METABOLISM PRODUCTS |
| US4527062A (en) * | 1983-07-05 | 1985-07-02 | The United States Of America As Represented By The Secretary Of The Navy | Portable infrared spectrophotometer |
| DE3344019C2 (en) * | 1983-12-06 | 1995-05-04 | Max Planck Gesellschaft | Device for optically measuring the concentration of a component contained in a sample |
| ATE42673T1 (en) * | 1984-05-04 | 1989-05-15 | Kurashiki Boseki Kk | SPECTROPHOTOMETRIC DEVICE FOR THE BLOOD-FREE DETERMINATION OF GLUCOSE IN LIVING TISSUE. |
| EP0184600B1 (en) * | 1984-12-10 | 1990-03-14 | Prutec Limited | Method for optically ascertaining parameters of species in a liquid analyte |
| DE3480490D1 (en) * | 1984-12-10 | 1989-12-21 | Prutec Ltd | Optical test probe and apparatus for optically determining species in solution |
| EP0221005A3 (en) * | 1985-09-07 | 1987-12-02 | Wagner, Wolfgang, Dr.med. | Injection device with sensor |
| US4704029A (en) * | 1985-12-26 | 1987-11-03 | Research Corporation | Blood glucose monitor |
| US4962021A (en) * | 1986-06-20 | 1990-10-09 | Personal Diagnostics, Inc. | Analyte determination using gel including a reagent system reacts with analyte to change transmissive property of gel detectable by light beam transmitted through gel by total internal reflectance |
| US4901728A (en) * | 1988-05-31 | 1990-02-20 | Eol, Inc. | Personal glucose monitor |
| GB8818690D0 (en) * | 1988-08-05 | 1988-09-07 | Red Kite Technology Ltd | Refractive index measurement |
| ATE80225T1 (en) * | 1989-05-23 | 1992-09-15 | Biosensors Technology Inc | METHOD OF DETERMINING SUBSTANCES IN ABSORBING AND SCATTERING MATRIX MATERIALS BY RADIATION ABSORPTION. |
| US5178142A (en) * | 1989-05-23 | 1993-01-12 | Vivascan Corporation | Electromagnetic method and apparatus to measure constituents of human or animal tissue |
| US5112124A (en) * | 1990-04-19 | 1992-05-12 | Worcester Polytechnic Institute | Method and apparatus for measuring the concentration of absorbing substances |
| US5137023A (en) * | 1990-04-19 | 1992-08-11 | Worcester Polytechnic Institute | Method and apparatus for monitoring blood analytes noninvasively by pulsatile photoplethysmography |
| US5183042A (en) * | 1989-05-23 | 1993-02-02 | Vivascan Corporation | Electromagnetic method and apparatus to measure constituents of human or animal tissue |
| CA2028261C (en) * | 1989-10-28 | 1995-01-17 | Won Suck Yang | Non-invasive method and apparatus for measuring blood glucose concentration |
| US5222495A (en) * | 1990-02-02 | 1993-06-29 | Angiomedics Ii, Inc. | Non-invasive blood analysis by near infrared absorption measurements using two closely spaced wavelengths |
| US5239180A (en) * | 1990-02-02 | 1993-08-24 | Boston Advnaced Technologies, Inc. | Laser systems for food analysis based on reflectance ratio detection |
| US5222496A (en) * | 1990-02-02 | 1993-06-29 | Angiomedics Ii, Inc. | Infrared glucose sensor |
| US5246004A (en) * | 1990-02-02 | 1993-09-21 | Angiomedics Ii, Inc. | Infrared cholesterol sensor |
| US5168325A (en) * | 1990-02-28 | 1992-12-01 | Board Of Control Of Michigan Technological University | Interferometric measurement of glucose by refractive index determination |
| US5115133A (en) * | 1990-04-19 | 1992-05-19 | Inomet, Inc. | Testing of body fluid constituents through measuring light reflected from tympanic membrane |
| US5079421A (en) * | 1990-04-19 | 1992-01-07 | Inomet, Inc. | Invasive FTIR blood constituent testing |
| US5209231A (en) * | 1990-11-02 | 1993-05-11 | University Of Connecticut | Optical glucose sensor apparatus and method |
| DK181191D0 (en) * | 1991-11-04 | 1991-11-04 | Novo Nordisk As | APPARATUS |
| US5277181A (en) * | 1991-12-12 | 1994-01-11 | Vivascan Corporation | Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis |
| AU2245092A (en) * | 1991-12-31 | 1993-07-28 | Vivascan Corporation | Blood constituent determination based on differential spectral analysis |
| US5452716A (en) * | 1992-02-25 | 1995-09-26 | Novo Nordisk A/S | Method and device for in vivo measuring the concentration of a substance in the blood |
| DK39792D0 (en) * | 1992-03-25 | 1992-03-25 | Foss Electric As | PROCEDURE FOR DETERMINING A COMPONENT |
| DE4227813A1 (en) * | 1992-08-21 | 1994-02-24 | Kim Yoon Ok | Device for the qualitative and / or quantitative determination of a sample to be analyzed |
| US5379764A (en) * | 1992-12-09 | 1995-01-10 | Diasense, Inc. | Non-invasive determination of analyte concentration in body of mammals |
| DE4243142A1 (en) * | 1992-12-19 | 1994-06-23 | Boehringer Mannheim Gmbh | Device for in-vivo determination of an optical property of the aqueous humor of the eye |
| US5615672A (en) * | 1993-01-28 | 1997-04-01 | Optiscan, Inc. | Self-emission noninvasive infrared spectrophotometer with body temperature compensation |
| US5344133A (en) * | 1993-02-25 | 1994-09-06 | Eastman Kodak Company | Vacuum belt feeder having a positive air pressure separator and method of using a vacuum belt feeder |
| SE501668C2 (en) * | 1993-08-06 | 1995-04-10 | Biolin Medical Ab | Quantification of CD transferrin at high alcohol consumption by HPLC |
| EP0670143B1 (en) * | 1993-08-12 | 2003-05-28 | Kurashiki Boseki Kabushiki Kaisha | Non invasive method and instrument for measuring blood sugar level |
| JP2807777B2 (en) * | 1994-09-09 | 1998-10-08 | 工業技術院長 | Optical absorption spectrum measuring device using slab optical waveguide |
| JP2802361B2 (en) * | 1994-10-07 | 1998-09-24 | 工業技術院長 | Dew point measuring device using slab optical waveguide |
| EP0714024B1 (en) * | 1994-11-25 | 2002-01-30 | Kyoto Dai-ichi Kagaku Co., Ltd. | Method of and apparatus for determining hydrogen peroxide |
| US5591407A (en) * | 1995-04-21 | 1997-01-07 | American Research Corporation Of Virginia | Laser diode sensor |
| US5743262A (en) * | 1995-06-07 | 1998-04-28 | Masimo Corporation | Blood glucose monitoring system |
| US6240306B1 (en) | 1995-08-09 | 2001-05-29 | Rio Grande Medical Technologies, Inc. | Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration |
| US6072180A (en) * | 1995-10-17 | 2000-06-06 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra from living tissue |
| US6025597A (en) * | 1995-10-17 | 2000-02-15 | Optiscan Biomedical Corporation | Non-invasive infrared absorption spectrometer for measuring glucose or other constituents in a human or other body |
| US5980831A (en) * | 1996-06-17 | 1999-11-09 | Braiman; Mark S. | Support planar germanium waveguides for infrared evanescent-wave sensing |
| US6161028A (en) | 1999-03-10 | 2000-12-12 | Optiscan Biomedical Corporation | Method for determining analyte concentration using periodic temperature modulation and phase detection |
| US7890158B2 (en) | 2001-06-05 | 2011-02-15 | Lumidigm, Inc. | Apparatus and method of biometric determination using specialized optical spectroscopy systems |
| US6628809B1 (en) | 1999-10-08 | 2003-09-30 | Lumidigm, Inc. | Apparatus and method for identification of individuals by near-infrared spectrum |
| EP1037553B1 (en) * | 1997-11-12 | 2007-01-24 | Lightouch Medical, Inc. | Method for non-invasive measurement of an analyte |
| EP0935131A3 (en) | 1998-02-05 | 2000-03-15 | Fuji Photo Film Co., Ltd. | Surface plasmon resonance sensor with wavelength-stabilized laser light source |
| DE59903899D1 (en) | 1998-03-06 | 2003-02-06 | Rudolf H Dittel | Measuring device for determining the concentration content of substances contained in liquids using an ATR element. |
| US6226082B1 (en) | 1998-06-25 | 2001-05-01 | Amira Medical | Method and apparatus for the quantitative analysis of a liquid sample with surface enhanced spectroscopy |
| AU4970499A (en) | 1998-07-07 | 2000-01-24 | Lightouch Medical, Inc. | Tissue modulation process for quantitative noninvasive in vivo spectroscopic analysis of tissues |
| US6277651B1 (en) | 1998-07-09 | 2001-08-21 | Calspan Srl Corporation | Diode laser electrochemical sensor for detecting chemical and biological analytes |
| US6424851B1 (en) | 1998-10-13 | 2002-07-23 | Medoptix, Inc. | Infrared ATR glucose measurement system (II) |
| EP1137364A2 (en) * | 1998-10-13 | 2001-10-04 | Medoptix, Inc. | Infrared atr glucose measurement system |
| EP1141762A1 (en) * | 1998-12-17 | 2001-10-10 | Leica Microsystems Heidelberg GmbH | Method for differentiated investigation of diverse structures in preferably biological preparations |
| US6198949B1 (en) | 1999-03-10 | 2001-03-06 | Optiscan Biomedical Corporation | Solid-state non-invasive infrared absorption spectrometer for the generation and capture of thermal gradient spectra from living tissue |
| US7577469B1 (en) * | 1999-03-11 | 2009-08-18 | Jack L. Aronowitz | Noninvasive transdermal systems for detecting an analyte in a biological fluid and methods |
| US6816605B2 (en) | 1999-10-08 | 2004-11-09 | Lumidigm, Inc. | Methods and systems for biometric identification of individuals using linear optical spectroscopy |
| WO2001058355A1 (en) * | 2000-02-07 | 2001-08-16 | Matsushita Electric Industrial Co., Ltd. | Biological information collecting probe, biological information measuring instrument, method for producing biological information collecting probe, and biological information measuring method |
| AU2001273412A1 (en) * | 2000-07-11 | 2002-01-21 | Lightouch Medical, Inc. | Method of tissue modulation for noninvasive measurement of an analyte |
| US6522903B1 (en) * | 2000-10-19 | 2003-02-18 | Medoptix, Inc. | Glucose measurement utilizing non-invasive assessment methods |
| US6983176B2 (en) | 2001-04-11 | 2006-01-03 | Rio Grande Medical Technologies, Inc. | Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy |
| US6862091B2 (en) | 2001-04-11 | 2005-03-01 | Inlight Solutions, Inc. | Illumination device and method for spectroscopic analysis |
| US7126682B2 (en) | 2001-04-11 | 2006-10-24 | Rio Grande Medical Technologies, Inc. | Encoded variable filter spectrometer |
| US6574490B2 (en) | 2001-04-11 | 2003-06-03 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
| US6865408B1 (en) | 2001-04-11 | 2005-03-08 | Inlight Solutions, Inc. | System for non-invasive measurement of glucose in humans |
| JP3834224B2 (en) * | 2001-06-28 | 2006-10-18 | 株式会社アドバンテスト | Chemical substance detection method and apparatus |
| US7027848B2 (en) | 2002-04-04 | 2006-04-11 | Inlight Solutions, Inc. | Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte |
| US7003337B2 (en) * | 2002-04-26 | 2006-02-21 | Vivascan Corporation | Non-invasive substance concentration measurement using and optical bridge |
| US8175666B2 (en) * | 2002-04-26 | 2012-05-08 | Grove Instruments, Inc. | Three diode optical bridge system |
| US7620212B1 (en) | 2002-08-13 | 2009-11-17 | Lumidigm, Inc. | Electro-optical sensor |
| CN100483106C (en) * | 2002-09-29 | 2009-04-29 | 天津市先石光学技术有限公司 | Optical method for detecting discerptible medium skin layer and deep layer information |
| US7093166B2 (en) * | 2002-10-08 | 2006-08-15 | Dell Products L.P. | Method and apparatus for testing physical memory in an information handling system under conventional operating systems |
| US7233817B2 (en) * | 2002-11-01 | 2007-06-19 | Brian Yen | Apparatus and method for pattern delivery of radiation and biological characteristic analysis |
| US6836678B2 (en) * | 2003-02-13 | 2004-12-28 | Xiang Zheng Tu | Non-invasive blood glucose monitor |
| US7668350B2 (en) | 2003-04-04 | 2010-02-23 | Lumidigm, Inc. | Comparative texture analysis of tissue for biometric spoof detection |
| US7545963B2 (en) | 2003-04-04 | 2009-06-09 | Lumidigm, Inc. | Texture-biometrics sensor |
| US7751594B2 (en) | 2003-04-04 | 2010-07-06 | Lumidigm, Inc. | White-light spectral biometric sensors |
| US7460696B2 (en) | 2004-06-01 | 2008-12-02 | Lumidigm, Inc. | Multispectral imaging biometrics |
| US7394919B2 (en) | 2004-06-01 | 2008-07-01 | Lumidigm, Inc. | Multispectral biometric imaging |
| US7627151B2 (en) | 2003-04-04 | 2009-12-01 | Lumidigm, Inc. | Systems and methods for improved biometric feature definition |
| US7539330B2 (en) | 2004-06-01 | 2009-05-26 | Lumidigm, Inc. | Multispectral liveness determination |
| AU2004227886A1 (en) | 2003-04-04 | 2004-10-21 | Lumidigm, Inc. | Multispectral biometric sensor |
| US7347365B2 (en) | 2003-04-04 | 2008-03-25 | Lumidigm, Inc. | Combined total-internal-reflectance and tissue imaging systems and methods |
| US20040225206A1 (en) * | 2003-05-09 | 2004-11-11 | Kouchnir Mikhail A. | Non-invasive analyte measurement device having increased signal to noise ratios |
| US7263213B2 (en) | 2003-12-11 | 2007-08-28 | Lumidigm, Inc. | Methods and systems for estimation of personal characteristics from biometric measurements |
| US20050137469A1 (en) * | 2003-12-17 | 2005-06-23 | Berman Herbert L. | Single detector infrared ATR glucose measurement system |
| US20050171413A1 (en) * | 2004-02-04 | 2005-08-04 | Medoptix, Inc. | Integrated device for non-invasive analyte measurement |
| US7508965B2 (en) | 2004-06-01 | 2009-03-24 | Lumidigm, Inc. | System and method for robust fingerprint acquisition |
| US20110163163A1 (en) * | 2004-06-01 | 2011-07-07 | Lumidigm, Inc. | Multispectral barcode imaging |
| US8229185B2 (en) | 2004-06-01 | 2012-07-24 | Lumidigm, Inc. | Hygienic biometric sensors |
| US8787630B2 (en) | 2004-08-11 | 2014-07-22 | Lumidigm, Inc. | Multispectral barcode imaging |
| US7801338B2 (en) * | 2005-04-27 | 2010-09-21 | Lumidigm, Inc. | Multispectral biometric sensors |
| EP1820441A1 (en) * | 2006-02-16 | 2007-08-22 | Roche Diagnostics GmbH | Microneedle arrays with attenuated total reflection (ATR) sensor |
| US8175346B2 (en) | 2006-07-19 | 2012-05-08 | Lumidigm, Inc. | Whole-hand multispectral biometric imaging |
| US8355545B2 (en) | 2007-04-10 | 2013-01-15 | Lumidigm, Inc. | Biometric detection using spatial, temporal, and/or spectral techniques |
| US7995808B2 (en) | 2006-07-19 | 2011-08-09 | Lumidigm, Inc. | Contactless multispectral biometric capture |
| CN101506826A (en) | 2006-07-19 | 2009-08-12 | 光谱辨识公司 | Multibiometric multispectral imager |
| US7801339B2 (en) | 2006-07-31 | 2010-09-21 | Lumidigm, Inc. | Biometrics with spatiospectral spoof detection |
| US7804984B2 (en) | 2006-07-31 | 2010-09-28 | Lumidigm, Inc. | Spatial-spectral fingerprint spoof detection |
| CN100512752C (en) * | 2007-01-12 | 2009-07-15 | 天津市先石光学技术有限公司 | Optical distance optional type atraumatic human body component measuring method and apparatus therefor |
| JP2008224452A (en) * | 2007-03-13 | 2008-09-25 | Hamamatsu Photonics Kk | Device for measuring totally reflected terahertz wave |
| EP2120713A2 (en) | 2007-03-21 | 2009-11-25 | Lumidigm, Inc. | Biometrics based on locally consistent features |
| BR112012004177A2 (en) | 2009-08-26 | 2016-03-29 | Lumidigm Inc | biometric method and system, system, method, object location, object discrimination, and background methods, and multifaceted prism |
| US8570149B2 (en) | 2010-03-16 | 2013-10-29 | Lumidigm, Inc. | Biometric imaging using an optical adaptive interface |
| WO2012109116A2 (en) * | 2011-02-07 | 2012-08-16 | Quantum Catch, Llc | Noninvasive eye-property monitoring, including aqueous-humor glucose monitoring as an indication of blood glucose level |
| KR102303829B1 (en) * | 2014-09-03 | 2021-09-17 | 삼성전자주식회사 | Noninvasive apparatus for testing glycated hemoglobin and noninvasive method for testing glycated hemoglobin |
| KR102390874B1 (en) | 2014-10-29 | 2022-04-26 | 삼성전자주식회사 | Glucose measure apparatus and method of measuring glucose thereof |
| EP3248544B1 (en) * | 2015-01-21 | 2021-12-08 | National Institutes for Quantum Science and Technology | Device for measuring concentration of substance in blood, and method for measuring concentration of substance in blood |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3308709A (en) * | 1963-06-12 | 1967-03-14 | Philips Corp | Multiple reflection optical device |
| US3313290A (en) * | 1963-08-14 | 1967-04-11 | Research Corp | Spectrofluorometer |
| FR1474447A (en) * | 1965-04-01 | 1967-03-24 | Philips Nv | optical element, in particular for internal reflection spectroscopy |
| DE1917588A1 (en) * | 1969-04-05 | 1970-10-15 | Kyffhaeuserhuette Veb Maschf | Method and device for the continuous measurement of the milk fat content in milk |
| CH501923A (en) * | 1969-07-02 | 1971-01-15 | Antenen Karl Dipl Phys Dr | Method for the spectroscopic examination of material from an animal or human body |
| DE2164670A1 (en) * | 1971-12-24 | 1973-06-28 | Bbc Brown Boveri & Cie | PROCEDURE FOR CONTINUOUS MEASUREMENT OF ORGANIC SUBSTANCES IN WATER AND ARRANGEMENT FOR CARRYING OUT THE PROCEDURE |
| US3902807A (en) * | 1973-10-25 | 1975-09-02 | Du Pont | Method for operating an attenuated total reflection infrared system |
-
1976
- 1976-02-20 DE DE19762606991 patent/DE2606991A1/en not_active Ceased
-
1977
- 1977-01-25 JP JP647777A patent/JPS52102094A/en active Pending
- 1977-02-17 US US05/769,777 patent/US4169676A/en not_active Expired - Lifetime
- 1977-02-18 LU LU76810A patent/LU76810A1/xx unknown
- 1977-02-18 NL NL7701778A patent/NL7701778A/en not_active Application Discontinuation
- 1977-02-18 BE BE175080A patent/BE851606A/en unknown
- 1977-02-18 FR FR7704735A patent/FR2341866A1/en not_active Withdrawn
- 1977-02-18 IT IT67375/77A patent/IT1071579B/en active
- 1977-02-18 CH CH203377A patent/CH612271A5/xx not_active IP Right Cessation
- 1977-02-18 GB GB6861/77A patent/GB1531375A/en not_active Expired
- 1977-02-18 CA CA272,129A patent/CA1084300A/en not_active Expired
- 1977-02-21 SE SE7701901A patent/SE7701901L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CH612271A5 (en) | 1979-07-13 |
| JPS52102094A (en) | 1977-08-26 |
| DE2606991A1 (en) | 1977-08-25 |
| BE851606A (en) | 1977-06-16 |
| NL7701778A (en) | 1977-08-23 |
| SE7701901L (en) | 1977-08-21 |
| LU76810A1 (en) | 1977-07-06 |
| GB1531375A (en) | 1978-11-08 |
| US4169676A (en) | 1979-10-02 |
| FR2341866A1 (en) | 1977-09-16 |
| IT1071579B (en) | 1985-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1084300A (en) | Instrument for determining the contents of metabolic products in the blood | |
| US4882492A (en) | Non-invasive near infrared measurement of blood analyte concentrations | |
| US4427889A (en) | Method and apparatus for molecular spectroscopy, particularly for the determination of products of metabolism | |
| EP1028318B1 (en) | Device for the optical measurement of the total hemoglobin concentration | |
| EP0948284B1 (en) | Monitoring of tissue analytes by infrared radiation | |
| US5379764A (en) | Non-invasive determination of analyte concentration in body of mammals | |
| CA2080691C (en) | Method and apparatus for measuring the concentration of absorbing substances | |
| US7096124B2 (en) | Method of determining an analyte concentration in a sample from an absorption spectrum | |
| US7079252B1 (en) | Dual beam FTIR methods and devices for use in analyte detection in samples of low transmissivity | |
| US5183042A (en) | Electromagnetic method and apparatus to measure constituents of human or animal tissue | |
| US3820901A (en) | Measurement of concentrations of components of a gaseous mixture | |
| DE2944113C2 (en) | ||
| Brinley et al. | Ionized magnesium concentration in axoplasm of dialyzed squid axons | |
| CA2183085A1 (en) | Method and apparatus for non-invasive detection of physiological chemicals, particularly glucose | |
| CA2951580A1 (en) | Non-invasive substance analysis using an optical medium and excitation and measurement light beams | |
| AU6425899A (en) | Methods and apparatus for tailoring spectroscopic calibration models | |
| EP3051272A2 (en) | Method for assaying lipids and other interferents in body fluid samples | |
| EP0635570A2 (en) | Blood culture sensor station utilizing two distinct light sources | |
| Valenzeno et al. | Measurement of cell lysis by light scattering | |
| CN101969837A (en) | Apparatus and method using light retro-reflected from a retina to non-invasively measure the blood concentration of a substance | |
| JPH11507127A (en) | Sample carrier used for infrared transmission spectroscopy | |
| US5168325A (en) | Interferometric measurement of glucose by refractive index determination | |
| CA2067248C (en) | Multi-wavelength pyrometer | |
| Smock et al. | Vapor phase determination of blood ammonia by an optical waveguide technique | |
| Coleman et al. | Fiber optic based sensor for bioanalytical absorbance measurements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |